Abstract
摘要
相似文献
1
[Letter: Potassium retaining diuretics].
Duodecim. 1974;90(23):1691-4.
2
[Spirolactones and potassium-sparing diuretics].
Rev Prat. 1978 Nov 11;28(51):4021-4, 4027-8, 4031-2.
3
The physiopathologic basis and limitations of treatment of cirrhotic edema with diuretics retaining potassium.
Mater Med Pol. 1974 Jul-Sep;6(3):199-201.
4
[Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
Schweiz Med Wochenschr. 1971 Mar 20;101(11):398-401.
5
[Potassium-saving effects of amiloride, triamterene and spironolactone].
Verh Dtsch Ges Inn Med. 1976;82 Pt 2:1514-7.
6
[Pharmacology of potassium-sparing diuretics: amiloride and triamterene].[保钾利尿剂的药理学：阿米洛利和氨苯蝶啶]
Coeur Med Interne. 1978 Apr-Jun;17(2):207-15.
7
Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop.
Horm Metab Res. 1976 May;8(3):250-1. doi: 10.1055/s-0028-1095614.
8
Potassium-sparing diuretics: spironolactone v. triamterene and amiloride.保钾利尿剂：螺内酯与氨苯蝶啶和阿米洛利的比较
Drug Ther Bull. 1972 Apr 14;10(8):30-2.
9
[Antikaliuretic agents].
Internist (Berl). 1971 Aug;12:Suppl:352-6.
10
Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.螺内酯和氨氯吡咪治疗低肾素性醛固酮增多症及相关综合征。
Clin Sci Mol Med Suppl. 1973 Aug;45 Suppl 1:213s-8. doi: 10.1042/cs045213s.
Zotero 插件